google-site-verification: googlec7193c3de77668c9.html

Biomarker-matched drug combos shrink treatment-resistant melanoma in preclinical models

[
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific tumor biology to improve outcomes for treatment-resistant advanced melanoma.


Source link

Advertisements
Views: 1

See also  Working arrangements for locum doctors pose significant patient safety challenges, finds study

Check Also

Low-cost treatment for multiple sclerosis shown to be as effective as standard therapy

[ A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that …

New biological clues behind coffee’s benefit to liver health

[ Credit: Skylar Kang from Pexels In one of the most comprehensive studies of coffee …

Woman’s Hour – Child mental health services, Amanda Wakeley, murder of Annabel Rook

Available for over a year Before the potential Prime Minister has even taken up office, …

Leave a Reply

Available for Amazon Prime